SCHEMBL7687461

SCHEMBL7687461

O=C(O)c1cnc2cc([N+](=O)[O-])ccc2c1O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.49
TDP1 Q9NUW8 3/20 0.49
CYP3A4 P08684 1/20 0.49
ALOX15 P16050 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 3/20 0.46
S100A4 P26447 1/20 0.46
BCL2L1 Q07817 1/20 0.45
MCL1 Q07820 1/20 0.45
EGFR P00533 2/20 0.45
HTT P42858 2/20 0.43
TP53 P04637 1/20 0.43
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11322508 0.90 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4ALOX15SMN1; SMN2
SCHEMBL538232 0.80 SMN1; SMN2 (0.55) ALDH1A1SMN1; SMN2MAPTHTTTP53
SCHEMBL27337635 0.79 MAPT (0.43) ALDH1A1MAPTS100A4EGFRHTT
SCHEMBL5767408 0.77 KEAP1 (0.42) ALDH1A1MAPTHTTMEN1GAA
SCHEMBL5766222 0.77 ALDH1A1 (0.47) ALDH1A1MCL1HTTMEN1GAA
SCHEMBL2724263 0.77 HTT (0.45) ALDH1A1MAPTBCL2L1MCL1EGFR
SCHEMBL1610495 0.77 CYP1A2 (0.49) ALDH1A1CYP3A4SMN1; SMN2MAPTMCL1
SCHEMBL1617941 0.77 HSD17B10 (0.41) ALDH1A1MAPTMCL1HTTMEN1
SCHEMBL30592903 0.77 CYP1A2 (0.49) ALDH1A1CYP3A4SMN1; SMN2MAPTMCL1
Hydrochloric Acid SCHEMBL11866946 0.76 CYP1A2 (0.48) ALDH1A1CYP3A4SMN1; SMN2MAPTMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002000622-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-01-03 WO disclosed